XML 58 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Compensation Cost on Net Earnings
The Company’s results for the years ended December 31, 2024, 2023 and 2022 reflected the following compensation cost and such compensation cost had the following effects on net earnings:
 Increase/(Decrease) for the
Year Ended December 31,
 202420232022
Cost of sales$1,716 $1,900 $1,302 
Operating expenses14,960 14,152 11,922 
Net earnings(12,865)(12,375)(10,214)
Schedule of Assumptions Used in the Valuation of Option Awards Risk-free interest rates are based on the implied yields currently available on U.S. Treasury zero coupon issues with a remaining term equal to the expected life.
Year Ended December 31,
Weighted Average Assumptions:202420232022
Expected Volatility28.4 %28.1 %30.3 %
Expected Term (in years)5.04.87.3
Risk-Free Interest Rate4.1 %3.9 %2.8 %
Dividend Yield0.6 %0.5 %0.5 %
Summary of Stock Option Activity
A summary of stock option plan activity for 2024, 2023, and 2022 for all plans is as follows:
202420232022
# of
Shares
(000s)		Weighted Average
Exercise Price		# of
Shares
(000s)		Weighted Average
Exercise Price		# of
Shares
(000s)		Weighted Average
Exercise Price
Outstanding at beginning of year1,078 $104.38 1,045 $99.82 867 $88.19 
Granted113 143.43 109 138.09 239 139.04 
Exercised(221)77.81 (64)81.98 (44)73.58 
Forfeited(8)139.64 (11)131.79 (17)124.89 
Cancelled— — (1)138.07 — — 
Outstanding at end of year962 $114.81 1,078 $104.38 1,045 $99.82 
Exercisable at end of year603 $99.59 720 $88.49 654 $81.95 
Schedule of Other Information Pertaining to Stock Option Activity
Other information pertaining to option activity during the years ended December 31, 2024, 2023 and 2022 is as follows:

 Years Ended December 31,
 202420232022
Weighted-average fair value of options granted$44.52 $40.91 $44.77 
Total intrinsic value of stock options exercised ($000s)$18,631 $3,241 $2,713 
Schedule of Additional Information Relating to Stock Options Outstanding
Additional information related to stock options outstanding under all plans at December 31, 2024 is as follows:

  Options OutstandingOptions Exercisable
Range of Exercise
Prices		Shares
Outstanding
(000s)		Weighted
Average
Remaining
Contractual
 Term		Weighted
Average
 Exercise
Price		Number
Exercisable
(000s)		Weighted
Average
Exercise
Price
$58.52 - $85.33
222 3.1$76.14 222 $76.14 
$85.40 - $118.60
212 4.0101.92 212 101.92 
$118.96 - $150.85
528 7.6136.24 169 127.47 
 962 5.8$114.81 603 $99.59 
Schedule of Non-vested Restricted Stock Activity
Non-vested restricted stock activity for the years ended December 31, 2024, 2023 and 2022 is summarized below:
202420232022
 Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance at beginning of year 116 $133.06 122 $124.42 166 $99.70 
Granted51 147.98 40 137.20 46 137.17 
Vested(39)124.63 (42)112.30 (82)82.15 
Forfeited(6)140.70 (4)128.06 (8)118.07 
Non-vested balance at end of year 122 $141.62 116 $133.06 122 $124.42 
Schedule of Non-vested Performance Share Activity
Non-vested performance share activity for the years ended December 31, 2024, 2023 and 2022 is summarized below:

202420232022
 Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value		Shares (000s)Weighted
Average Grant
Date Fair
Value
Non-vested balance at beginning of year 76 $135.25 70 $127.69 69 $110.72 
Granted47 152.28 42 139.66 39 114.22 
Vested(44)106.57 (36)98.84 (35)53.17 
Forfeited— — — — (3)84.09 
Non-vested balance at end of year 79 $150.73 76 $135.25 70 $127.69